0000947871-22-000085.txt : 20220120 0000947871-22-000085.hdr.sgml : 20220120 20220120142536 ACCESSION NUMBER: 0000947871-22-000085 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220120 DATE AS OF CHANGE: 20220120 EFFECTIVENESS DATE: 20220120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Equilibre BioPharmaceuticals Corp. CENTRAL INDEX KEY: 0001831900 IRS NUMBER: 853484646 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-430166 FILM NUMBER: 22541928 BUSINESS ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-308-6000 MAIL ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001831900 Equilibre BioPharmaceuticals Corp. 430 E 29TH ST. NEW YORK NY NEW YORK 10016 (332) 400-0300 DELAWARE Equilibre Newco A Corp. None Corporation true 2020 Samuel Waksal 430 E 29th St. New York NY NEW YORK 10016 Executive Officer Director Steven Gordon 430 E 29th St. New York NY NEW YORK 10016 Executive Officer Director Francois Maisonrouge 430 E 29th St. New York NY NEW YORK 10016 Director Joel Marcus 430 E 29th St. New York NY NEW YORK 10016 Director David Friedman 430 E 29th St. New York NY NEW YORK 10016 Director Philip Barach 430 E 29th St. New York NY NEW YORK 10016 Director Peter Simon 430 E 29th St. New York NY NEW YORK 10016 Director Pharmaceuticals Decline to Disclose 06b false 2022-01-14 false true false 0 25000000 15902341 9097659 false 14 0 0 0 false Equilibre BioPharmaceuticals Corp. /s/ Steven Gordon Steven Gordon Chief Operating Officer and Secretary 2022-01-20